WHO Expert Committee on specifications for pharmaceutical preparations : fortieth report.
Material type:
- 9789241209373
- RS 51 .W67 2006

Item type | Current library | Home library | Collection | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|---|
![]() |
National University - Manila | LRC - Main General Circulation | Pharmacy | GC RS 51 .W67 2006 (Browse shelf(Opens below)) | c.1 | Available | NULIB000009476 |
Browsing LRC - Main shelves, Shelving location: General Circulation, Collection: Pharmacy Close shelf browser (Hides shelf browser)
![]() |
No cover image available |
![]() |
![]() |
![]() |
![]() |
![]() |
||
GC RS 421 .K54 1977 c.3 Jenkins' quantitative pharmaceutical chemistry / | GC RS 431.P38 .P47 1991 Peptide and protein drug delivery / | GC RS 455 .N37 2010 Textbook of forensic pharmacy / | GC RS 51 .W67 2006 WHO Expert Committee on specifications for pharmaceutical preparations : fortieth report. | GC RS 51 .W67 2007 WHO Expert Committee on specifications for pharmaceutical preparations : forty-first report. | GC RS 51 .W67 2010 WHO Expert Committee on specifications for pharmaceutical preparations : forty-fourth report. | GC RS 51 .W67 2011 WHO Expert Committee on specializations for pharmaceutical preparations : forty-fifth report. |
Includes bibliographical references.
Introduction -- General Policy -- Quality control- specifications and tests -- Quality control- international Reference Materials -- Quality control- national laboratories -- Quality assurance- Good Manufacturing Practices -- Quality assurance- inspection -- Quality assurance- distribution -- Quality assurance- risk analysis -- Quality assurance- stability -- Prequalification -- Regulatory guidance on interchangeability for multisource (generic) pharmaceutical products -- Donations of medicine
This report presents the recommendations of an international group of experts convened by the World Health Organization to consider matters concerning the quality assurance of pharmaceuticals and specifications for drug substances and dosage forms. Annexes include: a list of available international chemical reference substances and international infrared spectra; supplementary guidelines on good manufacturing practices for heating, ventilation and air-conditioning systems for non-sterile pharmaceutical dosage forms; updated supplementary guidelines on good manufacturing practices for the manufacture of herbal medicines; supplementary guidelines on good manufacturing practices for validation; good distribution practices for pharmaceutical products; a model quality assurance system for procurement agencies (recommendations for quality assurance systems focusing on prequalification of products and manufacturers, purchasing, storage and distribution of pharmaceutical products); multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability; a proposal to waive in vivo bioequivalence requirements for WHO Model List of Essential Medicines immediate-release, solid oral dosage forms; and additional guidance for organizations performing in vivo bioequivalence studies.
There are no comments on this title.